Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 5;13(6):176.
doi: 10.3390/diseases13060176.

The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal Mastitis

Affiliations
Review

The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal Mastitis

Mariarosaria Matera et al. Diseases. .

Abstract

Mastitis, an inflammatory condition of the breast, significantly affects breastfeeding women and can lead to the early cessation of lactation. This article explores the pathophysiology of mastitis, distinguishing between acute mastitis (AM) and subacute mastitis (SAM), with a focus on the microbial dynamics involved. AM is primarily associated with Staphylococcus aureus, while SAM is linked to a dysbiotic milk microbiota characterized by an imbalance of microbial species, including increased levels of opportunistic pathogens. The role of inflammation and the gut-breast axis in the development of mastitis are discussed, emphasizing the importance of maintaining a healthy microbiota. Recent studies highlight the potential of probiotics as a preventive and therapeutic measure against mastitis, showing promising results in reducing incidence and recurrence. However, further research is necessary to optimize probiotic strains, dosages, and treatment protocols. This review underscores the need for a comprehensive understanding of the microbiological, immunological, and inflammatory factors involved in mastitis to develop effective prevention and treatment strategies.

Keywords: breastfeeding; dysbiosis; inflammation; mastitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pathophysiology of mastitis from a microbiome perspective. DAMPs: damage-associated molecular patterns; PAMPs: pathogen-associated molecular patterns; and TLR: Toll-like receptors.
Figure 2
Figure 2
Milk dysbiosis as the origin of the risk of developing mastitis.

Similar articles

References

    1. Binns C., Lee M., Low W.Y. The Long-Term Public Health Benefits of Breastfeeding. Asia Pac. J. Public Health. 2016;28:7–14. doi: 10.1177/1010539515624964. - DOI - PubMed
    1. Meek J.Y., Noble L., Section on Breastfeeding Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 2022;150:e2022057988. doi: 10.1542/peds.2022-057988. - DOI - PubMed
    1. Andreas N.J., Kampmann B., Mehring Le-Doare K. Human breast milk: A review on its composition and bioactivity. Early Hum. Dev. 2015;91:629–635. doi: 10.1016/j.earlhumdev.2015.08.013. - DOI - PubMed
    1. Yi D., Kim S. Human Breast Milk Composition and Function in Human Health: From Nutritional Components to Microbiome and MicroRNAs. Nutrients. 2021;13:3094. doi: 10.3390/nu13093094. - DOI - PMC - PubMed
    1. Lyons K.E., Ryan C.A., Dempsey E.M., Ross R.P., Stanton C. Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health. Nutrients. 2020;12:1039. doi: 10.3390/nu12041039. - DOI - PMC - PubMed

LinkOut - more resources